| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 48.7156 | 44 |
| GSM780708 | Untreated after 4 days (C2_1) | 48.0816 | 41 |
| GSM780709 | Untreated after 4 days (C3_1) | 46.2613 | 33 |
| GSM780719 | Untreated after 4 days (C1_2) | 47.652 | 40 |
| GSM780720 | Untreated after 4 days (C2_2) | 39.6594 | 6 |
| GSM780721 | Untreated after 4 days (C3_2) | 40.4574 | 8 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 43.9096 | 22 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 39.9004 | 6 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 41.0468 | 10 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 38.9526 | 4 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 43.1988 | 18 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 46.6096 | 35 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 46.6156 | 35 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 50.5302 | 50 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 51.5688 | 53 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 41.8014 | 12 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 40.8021 | 9 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 45.4586 | 29 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 47.2988 | 38 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 44.2499 | 23 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 43.2778 | 19 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 47.3635 | 38 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 47.0129 | 37 |